Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium nitrite + n-acetylcysteine is a combination of two small molecule drugs. Sodium nitrite is an inorganic compound used medically as an antidote for cyanide poisoning and in other settings as a vasodilator. N-acetylcysteine (NAC) is a thiol-containing antioxidant and precursor to glutathione, widely used as an antidote for acetaminophen overdose, mucolytic agent, and in various experimental or adjunctive therapies due to its antioxidant and cytoprotective properties. The combination has been studied primarily in preclinical models for its potential protective effects against sodium nitrite-induced oxidative stress and tissue injury, with NAC mitigating the toxic effects of sodium nitrite by enhancing antioxidant defenses and reducing DNA damage[1][7]. Mechanistically, sodium nitrite acts by releasing nitric oxide (NO), leading to vasodilation via activation of guanylate cyclase; NAC acts both directly as a glutathione substitute/antioxidant and indirectly by replenishing intracellular glutathione levels[6][10]. There are no established brand names or approved pharmaceutical products combining these two agents specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium nitrite + n-acetylcysteine.